Verdad Advisers’s Braskem BAK Stock Holding History

Verdad Advisers’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-130,000	Closed	-$1M	–	48
2023 Q1	$1M	Buy	130,000 +5,591	+4%	+$45.4K	2.02%	22
2022 Q4	$1.14M	Buy	+124,409	New	+$1.38M	1.15%	17

Other funds holding BAK

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

BBP

Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return

Verdad Advisers's BAK Position: Q2 2023 in Review

Verdad Advisers sold out of Braskem (BAK) in Q2 2023, closing a stake of 130,000 shares — an estimated $1M sold.

Verdad Advisers first reported a position in BAK in Q4 2022 and held it in 2 quarters. The position peaked at $1.14M in Q4 2022. 59 funds tracked by Wall St. Rank hold BAK as of Q2 2023.

Verdad Advisers reported no remaining Braskem position as of Q2 2023 after selling out during the quarter.
Verdad Advisers sold 130,000 Braskem shares in Q2 2023, an estimated $1M.
Verdad Advisers first reported a position in Braskem in Q4 2022 and held it in 2 quarters.
Verdad Advisers's Braskem position peaked at $1.14M in Q4 2022.
59 funds tracked by Wall St. Rank held Braskem as of Q2 2023.

Based on Verdad Advisers's 13F filing for Q2 2023, filed 9 Aug 2023.